Radiology reports are essential for communicating imaging findings to guide diagnosis and treatment. Although most radiology reports are accurate, errors can occur in the final reports due to high workloads, use of dictation software, and human error. Advanced artificial intelligence models, such as GPT-4, show potential as tools to improve report accuracy. This retrospective study evaluated how GPT-4 performed in detecting and correcting errors in finalized radiology reports in real-world settings for abdominopelvic computed tomography (CT) reports. We evaluated finalized CT abdominopelvic reports from a tertiary health system by using GPT-4 with zero-shot learning techniques. Six radiologists each reviewed 100 of their finalized reports (randomly selected), evaluating GPT-4's suggested revisions for agreement, acceptance, and clinical impact. The radiologists' responses were compared by years in practice and sex. GPT-4 identified issues and suggested revisions for 91% of the 600 reports; most revisions addressed grammar (74%). The radiologists agreed with 27% of the revisions and accepted 23%. Most revisions were rated as having no (44%) or low (46%) clinical impact. Potential harm was rare (8%), with only 2 cases of potentially severe harm. Radiologists with less experience (≤ 7 years of practice) were more likely to agree with the revisions suggested by GPT-4 than those with more experience (34% vs. 20%, P = .003) and accepted a greater percentage of the revisions (32% vs. 15%, P = .003). Although GPT-4 showed promise in identifying errors and improving the clarity of finalized radiology reports, most errors were categorized as minor, with no or low clinical impact. Collectively, the radiologists accepted 23% of the suggested revisions in their finalized reports. This study highlights the potential of GPT-4 as a prospective tool for radiology reporting, with further refinement needed for consistent use in clinical practice.

Early-stage cirrhosis frequently presents without symptoms, making timely identification of high-risk patients challenging. We aimed to develop a deep learning-based triple-modal fusion liver cirrhosis network (TMF-LCNet) for the prediction of adverse outcomes, offering a promising tool to enhance early risk assessment and improve clinical management strategies. This retrospective study included 243 patients with early-stage cirrhosis across two centers. Adverse outcomes were defined as the development of severe complications like ascites, hepatic encephalopathy and variceal bleeding. TMF-LCNet was developed by integrating three types of data: non-contrast abdominal CT images, radiomic features extracted from liver and spleen, and clinical text detailing laboratory parameters and adipose tissue composition measurements. TMF-LCNet was compared with conventional methods on the same dataset, and single-modality versions of TMF-LCNet were tested to determine the impact of each data type. Model effectiveness was measured using the area under the receiver operating characteristics curve (AUC) for discrimination, calibration curves for model fit, and decision curve analysis (DCA) for clinical utility. TMF-LCNet demonstrated superior predictive performance compared to conventional image-based, radiomics-based, and multimodal methods, achieving an AUC of 0.797 in the training cohort (n = 184) and 0.747 in the external test cohort (n = 59). Only TMF-LCNet exhibited robust model calibration in both cohorts. Of the three data types, the imaging modality contributed the most, as the image-only version of TMF-LCNet achieved performance closest to the complete version (AUC = 0.723 and 0.716, respectively; p > 0.05). This was followed by the text modality, with radiomics contributing the least, a pattern consistent with the clinical utility trends observed in DCA. TMF-LCNet represents an accurate and robust tool for predicting adverse outcomes in early-stage cirrhosis by integrating multiple data types. It holds potential for early identification of high-risk patients, guiding timely interventions, and ultimately improving patient prognosis.

Artificial intelligence (AI) algorithms and deep learning continue to change the landscape of radiology. New algorithms promise to enhance diagnostic accuracy, improve workflow efficiency, and automate repetitive tasks. This article provides a narrative review of the FDA-cleared AI algorithms which are commercially available in the United States as of late 2024 and targeted toward assessment of abdominopelvic organs and related diseases, evaluates potential advantages of using AI, and suggests future directions for the field.

To develop a deep learning model based on Residual Networks (ResNet) for the automated and accurate identification of contrast phases in abdominal CT images. A dataset of 1175 abdominal contrast-enhanced CT scans was retrospectively collected for the model development, and another independent dataset of 215 scans from five hospitals was collected for external testing. Each contrast phase was independently annotated by two radiologists. A ResNet-based model was developed to automatically classify phases into the early arterial phase (EAP) or late arterial phase (LAP), portal venous phase (PVP), and delayed phase (DP). Strategy A identified EAP or LAP, PVP, and DP in one step. Strategy B used a two-step approach: first classifying images as arterial phase (AP), PVP, and DP, then further classifying AP images into EAP or LAP. Model performance and strategy comparison were evaluated. In the internal test set, the overall accuracy of the two-step strategy was 98.3% (283/288; p < 0.001), significantly higher than that of the one-step strategy (91.7%, 264/288; p < 0.001). In the external test set, the two-step model achieved an overall accuracy of 99.1% (639/645), with sensitivities of 95.1% (EAP), 99.4% (LAP), 99.5% (PVP), and 99.5% (DP). The proposed two-step ResNet-based model provides highly accurate and robust identification of contrast phases in abdominal CT images, outperforming the conventional one-step strategy. Automated and accurate identification of contrast phases in abdominal CT images provides a robust tool for improving image quality control and establishes a strong foundation for AI-driven applications, particularly those leveraging contrast-enhanced abdominal imaging data. Accurate identification of contrast phases is crucial in abdominal CT imaging. The two-step ResNet-based model achieved superior accuracy across internal and external datasets. Automated phase classification strengthens imaging quality control and supports precision AI applications.

Early identification of bowel resection risks is crucial for patients with incarcerated inguinal hernia (IIH). However, the prompt detection of these risks remains a significant challenge. Advancements in radiomic feature extraction and machine learning algorithms have paved the way for innovative diagnostic approaches to assess IIH more effectively. To devise a sophisticated radiomic-clinical model to evaluate bowel resection risks in IIH patients, thereby enhancing clinical decision-making processes. This single-center retrospective study analyzed 214 IIH patients randomized into training (<i>n</i> = 161) and test (<i>n</i> = 53) sets (3:1). Radiologists segmented hernia sac-trapped bowel volumes of interest (VOIs) on computed tomography images. Radiomic features extracted from VOIs generated Rad-scores, which were combined with clinical data to construct a nomogram. The nomogram's performance was evaluated against standalone clinical and radiomic models in both cohorts. A total of 1561 radiomic features were extracted from the VOIs. After dimensionality reduction, 13 radiomic features were used with eight machine learning algorithms to develop the radiomic model. The logistic regression algorithm was ultimately selected for its effectiveness, showing an area under the curve (AUC) of 0.828 [95% confidence interval (CI): 0.753-0.902] in the training set and 0.791 (95%CI: 0.668-0.915) in the test set. The comprehensive nomogram, incorporating clinical indicators showcased strong predictive capabilities for assessing bowel resection risks in IIH patients, with AUCs of 0.864 (95%CI: 0.800-0.929) and 0.800 (95%CI: 0.669-0.931) for the training and test sets, respectively. Decision curve analysis revealed the integrated model's superior performance over standalone clinical and radiomic approaches. This innovative radiomic-clinical nomogram has proven to be effective in predicting bowel resection risks in IIH patients and has substantially aided clinical decision-making.

Resistance exercise, Taichi exercise, and the hybrid exercise program consisting of the two aforementioned methods have been demonstrated to increase the skeletal muscle mass of older individuals with sarcopenia. However, the exercise sequence has not been comprehensively investigated. Therefore, we designed a self-determined sequence exercise program, incorporating resistance exercises, Taichi, and the hybrid exercise program to overcome the decline of skeletal muscle area and reverse sarcopenia in older individuals. Ninety-one older patients with sarcopenia between the ages of 60 and 75 completed this three-stage randomized controlled trial for 24 weeks, including the self-determined sequence exercise program group (n = 31), the resistance training group (n = 30), and the control group (n = 30). We used quantitative computed tomography to measure the effects of different intervention protocols on skeletal muscle mass in participants. Participants' demographic variables were analyzed using one-way analysis of variance and chi-square tests, and experimental data were examined using repeated-measures analysis of variance. Furthermore, we utilized the Markov model to explain the effectiveness of the exercise programs among the three-stage intervention and explainable artificial intelligence to predict whether intervention programs can reverse sarcopenia. Repeated-measures analysis of variance results indicated that there were statistically significant Group × Time interactions detected in the L3 skeletal muscle density, L3 skeletal muscle area, muscle fat infiltration, handgrip strength, and relative skeletal muscle mass index. The stacking model exhibited the best accuracy (84.5%) and the best F1-score (68.8%) compared to other algorithms. In the self-determined sequence exercise program group, strength training contributed most to the reversal of sarcopenia. One self-determined sequence exercise program can improve skeletal muscle area among sarcopenic older people. Based on our stacking model, we can predict whether sarcopenia in older people can be reversed accurately. The trial was registered in ClinicalTrials.gov. TRN:NCT05694117. Our findings indicate that such tailored exercise interventions can substantially benefit sarcopenic patients, and our stacking model provides an accurate predictive tool for assessing the reversibility of sarcopenia in older adults. This approach not only enhances individual health outcomes but also informs future development of targeted exercise programs to mitigate age-related muscle decline.

Accurate segmentation of hepatic and portal veins is critical for preoperative planning in liver surgery, especially for resection and transplantation procedures. Extensive anatomical variability, pathological alterations, and inherent class imbalance between background and vascular structures challenge this task. Current state-of-the-art deep learning approaches often fail to generalize across patient variability or maintain vascular topology, thus limiting their clinical applicability. To overcome these limitations, we propose the D²-RD-UNet, a dual-stage, dual-class segmentation framework for hepatic and portal vessels. The D²-RD-UNet architecture employs dense and residual connections to improve feature propagation and segmentation accuracy. Our D²-RD-UNet integrates advanced data-driven preprocessing, a dual-path architecture for 3D and 4D data, with the latter concatenating computed tomography (CT) scans with four relevant vesselness filters (Sato, Frangi, OOF, and RORPO). The pipeline is completed by the first developed postprocessing multi-class vessel connectivity correction algorithm based on centerlines. Additionally, we introduce the first radius-based branching algorithm to evaluate the model's predictions locally, providing detailed insights into the accuracy of vascular reconstructions at different scales. In order to make up for the scarcity of well-annotated open datasets for hepatic vessels segmentation, we curated AIMS-HPV-385, a large, pathological, multi-class, and validated dataset on 385 CT scans. We trained different configurations of D²-RD-UNet and state-of-the-art models on 327 CTs of AIMS-HPV-385. Experimental results on the remaining 58 CTs of AIMS-HPV-385 and on the 20 CTs of 3D-IRCADb-01 demonstrate superior performances of the D²-RD-UNet variants over state-of-the-art methods, achieving robust generalization, preserving vascular continuity, and offering a reliable approach for liver vascular reconstructions.

The clinical diagnosis of clear cell renal cell carcinoma (ccRCC) primarily depends on histopathological analysis and computed tomography (CT). Although pathological diagnosis is regarded as the gold standard, invasive procedures such as biopsy carry the risk of tumor dissemination. Conversely, CT scanning offers a non-invasive alternative, but its resolution may be inadequate for detecting microscopic tumor features, which limits the performance of prognostic assessments. To address this issue, we propose a high-order correlation-driven method for predicting the survival of ccRCC using only CT images, achieving performance comparable to that of the pathological gold standard. The proposed method utilizes a cross-modal hypergraph neural network based on hypergraph transfer learning to perform high-order correlation modeling and semantic feature extraction from whole-slide pathological images and CT images. By employing multi-kernel maximum mean discrepancy, we transfer the high-order semantic features learned from pathological images to the CT-based hypergraph neural network channel. During the testing phase, high-precision survival predictions were achieved using only CT images, eliminating the need for pathological images. This approach not only reduces the risks associated with invasive examinations for patients but also significantly enhances clinical diagnostic efficiency. The proposed method was validated using four datasets: three collected from different hospitals and one from the public TCGA dataset. Experimental results indicate that the proposed method achieves higher concordance indices across all datasets compared to other methods.

Post-surgical prediction of recurrence or metastasis for primary gastrointestinal stromal tumors (GISTs) remains challenging. We aim to develop individualized clinical follow-up strategies for primary GIST patients, such as shortening follow-up time or extending drug administration based on the clinical deep learning radiomics model (CDLRM). The clinical information on primary GISTs was collected from two independent centers. Postoperative recurrence or metastasis in GIST patients was defined as the endpoint of the study. A total of nine machine learning models were established based on the selected features. The performance of the models was assessed by calculating the area under the curve (AUC). The CDLRM with the best predictive performance was constructed. Decision curve analysis (DCA) and calibration curves were analyzed separately. Ultimately, our model was applied to the high-potential malignant group vs the low-malignant-potential group. The optimal clinical application scenarios of the model were further explored by comparing the DCA performance of the two subgroups. A total of 526 patients, 260 men and 266 women, with a mean age of 62 years, were enrolled in the study. CDLRM performed excellently with AUC values of 0.999, 0.963, and 0.995 for the training, external validation, and aggregated sets, respectively. The calibration curve indicated that CDLRM was in good agreement between predicted and observed probabilities in the validation cohort. The results of DCA's performance in different subgroups show that it was more clinically valuable in populations with high malignant potential. CDLRM could help the development of personalized treatment and improved follow-up of patients with a high probability of recurrence or metastasis in the future. This model utilizes imaging features extracted from CT scans (including radiomic features and deep features) and clinical data to accurately predict postoperative recurrence and metastasis in patients with primary GISTs, which has a certain auxiliary role in clinical decision-making. We developed and validated a model to predict recurrence or metastasis in patients taking oral imatinib after GIST. We demonstrate that CT image features were associated with recurrence or metastases. The model had good predictive performance and clinical benefit.

For magnetic resonance imaging (MRI), a short acquisition time and good image quality are incompatible. Thus, reconstructing time-resolved volumetric MRI (4D-MRI) to delineate and monitor thoracic and upper abdominal tumor movements is a challenge. Existing MRI sequences have limited applicability to 4D-MRI. A method is proposed for reconstructing high-quality personalized enhanced 4D-MR images. Low-quality 4D-MR images are scanned followed by deep learning-based personalization to generate high-quality 4D-MR images. High-speed multiphase 3D fast spoiled gradient recalled echo (FSPGR) sequences were utilized to generate low-quality enhanced free-breathing 4D-MR images and paired low-/high-quality breath-holding 4D-MR images for 58 liver cancer patients. Then, a personalized model guided by the paired breath-holding 4D-MR images was developed for each patient to cope with patient heterogeneity. The 4D-MR images generated by the personalized model were of much higher quality compared with the low-quality 4D-MRI images obtained by conventional scanning as demonstrated by significant improvements in the peak signal-to-noise ratio, structural similarity, normalized root mean square error, and cumulative probability of blur detection. The introduction of individualized information helped the personalized model demonstrate a statistically significant improvement compared to the general model (p < 0.001). The proposed method can be used to quickly reconstruct high-quality 4D-MR images and is potentially applicable to radiotherapy for liver cancer.